Seach Medical Group Ltd (TLV:SEMG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
277.60
0.00 (0.00%)
Apr 24, 2026, 1:47 PM IDT

Seach Medical Group Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
157.15171.72150.32134.2167.34
Revenue Growth (YoY)
-8.48%14.24%12.01%99.30%82.98%
Cost of Revenue
110.31114.09112.9395.9144.34
Gross Profit
46.8557.6337.438.323
Selling, General & Admin
33.6837.7538.2332.7416.16
Research & Development
0.80.981.761.452.31
Other Operating Expenses
-0.05-0.05-0.230.080.12
Operating Expenses
34.4438.6739.7634.2718.59
Operating Income
12.4118.96-2.374.034.41
Interest Expense
-1.22-1.45-1.81-0.94-0.17
Interest & Investment Income
0.410.390.250.010.25
Earnings From Equity Investments
-0.02-0.270.19-1.24-1
Currency Exchange Gain (Loss)
0.59----
Other Non Operating Income (Expenses)
-0.46-0.81-0.87-0.73-0.25
EBT Excluding Unusual Items
11.7216.83-4.611.143.24
Impairment of Goodwill
-8.04-2.27-5.76--
Gain (Loss) on Sale of Investments
-0.090.04-2.03-5.040.49
Gain (Loss) on Sale of Assets
0.040.02-0.32-0.170.01
Asset Writedown
-0.01-1.38---
Other Unusual Items
0.370.22.4402.49
Pretax Income
3.9913.42-10.28-4.076.23
Income Tax Expense
3.63-0.141.591.21.01
Earnings From Continuing Operations
0.3513.56-11.87-5.275.23
Minority Interest in Earnings
1.17-0.031.361.860.12
Net Income
1.5213.52-10.51-3.415.35
Net Income to Common
1.5213.52-10.51-3.415.35
Net Income Growth
-88.73%----55.30%
Shares Outstanding (Basic)
3334343434
Shares Outstanding (Diluted)
3434343434
Shares Change (YoY)
-1.42%0.03%-0.78%3.61%
EPS (Basic)
0.050.40-0.31-0.100.16
EPS (Diluted)
0.050.40-0.31-0.100.16
EPS Growth
-88.42%----56.86%
Free Cash Flow
16.4415.54-0.6716.16-10.02
Free Cash Flow Per Share
0.490.46-0.020.47-0.30
Dividend Per Share
0.1800.120---
Dividend Growth
50.00%----
Gross Margin
29.81%33.56%24.88%28.54%34.16%
Operating Margin
7.90%11.04%-1.57%3.00%6.55%
Profit Margin
0.97%7.88%-6.99%-2.54%7.94%
Free Cash Flow Margin
10.46%9.05%-0.44%12.04%-14.88%
EBITDA
14.1421.271.299.287.39
EBITDA Margin
9.00%12.38%0.86%6.92%10.97%
D&A For EBITDA
1.722.313.665.252.98
EBIT
12.4118.96-2.374.034.41
EBIT Margin
7.90%11.04%-1.57%3.00%6.55%
Effective Tax Rate
91.14%---16.14%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.